97.70
+0.70
+(0.72%)
At close: January 10 at 5:32:33 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 4 | 25 | 26 |
| Avg. Estimate | 15.49B | 16.47B | 63.98B | 67.49B |
| Low Estimate | 15.06B | 16.02B | 63.15B | 65.24B |
| High Estimate | 16B | 17.2B | 64.36B | 71.76B |
| Year Ago Sales | 14.63B | 15.78B | 60.12B | 63.98B |
| Sales Growth (year/est) | 5.91% | 4.38% | 6.43% | 5.48% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MRK.VI | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 1/8/2025 |
| Downgrade | Truist Securities: Buy to Hold | 1/8/2025 |
| Downgrade | BMO Capital: Outperform to Market Perform | 12/20/2024 |
| Initiated | Wolfe Research: Peer Perform | 11/15/2024 |
| Maintains | Truist Securities: Buy to Buy | 11/7/2024 |
| Maintains | Guggenheim: Buy to Buy | 11/6/2024 |
Related Tickers
JNJd.XC
600436.SS PIENTZEHUANG
204.40
-0.54%
NOVNEE.SW Novartis AG
91.37
-0.64%
COPNz.XC
ZEG.DE AstraZeneca PLC
131.25
+0.04%
JNJ.HM Johnson & Johnson
139.62
+1.20%
AZNCF AstraZeneca PLC
135.50
0.00%
PFE.DU Pfizer Inc
26.32
+1.08%
GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited
2,190.40
-0.81%
GLAXF GSK plc
16.86
0.00%